| Document Date: 2012-01-30 01:00:00
Open Document File Size: 667,95 KBShare Result on Facebook
City Tokyo / Winnipeg / / Company ADP / CanAm Bioresearch Inc. / Turpie AG / Loyola University Medical Centre / Aviva BioSciences / Nucro-Technics / AMES / Medicure Inc. / BioCascade / NoAb BioDiscoveries / MDS Pharma / Contact Dawson Reimer Medicure Inc. / / Country United States / Canada / / Currency USD / / / Event Business Partnership / / Facility Medicure’s library / University of Alberta / Montreal Heart Institute / / / IndustryTerm natural product / treatment of thromboembolic diseases / / MedicalCondition thromboembolic diseases / Arterial thrombosis / congestive heart failure / Market Cardiovascular disease / acute coronary syndromes / atherosclerosis / venous and arterial thrombosis / venous thrombosis / rat venous thrombosis / stroke / thrombocytopenia / both arterial and venous thrombosis / cerebrovascular disease / thromboembolic disorders / myocardial infarction / deep vein thrombosis / Coronary artery disease / Introduction Thrombosis / pulmonary embolism / peripheral artery disease / atrial fibrillation / thrombus / Thrombosis / / MedicalTreatment combination drug therapies / / Organization Montreal Heart Institute / Thrombosis Research Group Loyola University Medical Centre / University of Alberta / / Person Chen / V / / / Position Executive / / Product Coumadin / epinephrine / adenosine / argatroban / / ProvinceOrState Alberta / Prince Edward Island / Manitoba / / Technology pharmacokinetics / drug discovery / antibodies / CVD / CAD / /
SocialTag |
A Unique Dual Acting Inhibitor for Thrombosis: Combining Anticoagulant & Antiplatelet Effects into a Single Molecule Non-Confidential Dossier January 2012